[Prolonged use of paclitaxel for platinum-refractory ovarian cancer--brief report].
The patient was a 41-year-old women with platinum-refractory ovarian cancer. She received 135-210 mg/m2 paclitaxel for 13 cycles. She received granulocyte colony-stimulating factor (G-CSF) support to prevent severe granulocytopenia, and experienced little neurologic toxicity. Her quality of life was good throughout the prolonged period of use of paclitaxel.
Dept. of Obstetrics and Gynecology, Yamamoto Kumiai General Hospital.
H
H
Tanaka
Y
Y
Konishi
H
H
Saito
D000328:Adult; D000972:Antineoplastic Agents, Phytogenic / Q000008:administration & dosage*; D002945:Cisplatin / Q000627:therapeutic use; D004351:Drug Resistance; D005260:Female; D006801:Humans; D010051:Ovarian Neoplasms / Q000188:drug therapy*; D017239:Paclitaxel / Q000008:administration & dosage*; D011788:Quality of Life
D000972:Antineoplastic Agents, Phytogenic; D017239:Paclitaxel; D002945:Cisplatin